Company Filing History:
Years Active: 2023-2025
Title: N Tilani S De Costa: Innovator in Nucleic Acid Technologies
Introduction
N Tilani S De Costa is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of nucleic acid technologies, particularly through her innovative work on short interfering nucleic acid (siNA) molecules. With a total of three patents to her name, her research has the potential to impact various applications in biotechnology and medicine.
Latest Patents
N Tilani S De Costa's latest patents focus on modified short interfering nucleic acid (siNA) molecules and their uses. These patents describe siNA molecules that comprise modified nucleotides, including 2'-O-methyl nucleotides and 2′-fluoro nucleotides. The disclosed siNA molecules may be double-stranded and include features such as a phosphorylation blocker, conjugated moiety, or a 5′-stabilized end cap. These advancements in siNA technology open new avenues for therapeutic applications.
Career Highlights
N Tilani S De Costa is currently associated with Aligos Therapeutics, Inc., where she continues to advance her research in nucleic acid technologies. Her work is characterized by a commitment to innovation and a focus on developing effective solutions in the biotechnology sector.
Collaborations
Some of her notable coworkers include Leonid Beigelman and Vivek Kumar Rajwanshi. Their collaborative efforts contribute to the ongoing research and development in the field of nucleic acids.
Conclusion
N Tilani S De Costa is a trailblazer in the realm of nucleic acid technologies, with her patents reflecting her innovative spirit and dedication to advancing science. Her contributions are poised to make a lasting impact in biotechnology and medicine.